Introduction
============

Solitary pulmonary nodules (SPNs) are solitary and rounded nodular opacities located within the pulmonary parenchyma, not exceeding 3 cm in diameter ([@b1-etm-0-0-3528]). SPNs are not associated with pulmonary atelectasis, infection, hilar enlargement or enlarged mediastinal lymph nodes. As the rate of detection of early-stage pulmonary malignant tumors increases, one SPN appears in every 500 chest radiographs ([@b2-etm-0-0-3528]). SPNs are a common manifestation of multiple benign and malignant diseases and are usually asymptomatic. Qualitative diagnosis of SPNs shows obvious differences in the treatment and prognosis of lung cancer ([@b3-etm-0-0-3528]). The five-year survival rate of lung cancer is only 10--20%, while that of early-stage lung cancer can reach 70--85% ([@b4-etm-0-0-3528]).

At present, the diagnostic techniques for SPNs primarily include fiberoptic bronchoscopy, exfoliative cytology of sputum, chest X-ray, lung needle biopsy, thoracoscopic surgery, ^18^F-FDG PET/computed tomography (CT) functional imaging, rapid sequence MRI, and dynamic CT perfusion imaging and spectral CT ([@b5-etm-0-0-3528]). Dynamic CT perfusion imaging has proven effective in the early diagnosis of SPNs. High-resolution CT (HRCT), not only elevates the detection rate of SPNs, but also sufficiently allows for the analysis of internal density of the lesion, edge features, and the association between the lesion and surrounding structures ([@b6-etm-0-0-3528]).

The aim of the present study was to analyze the value of applying dual-source 64-layer spiral CT enhancement in the differential diagnosis of SPNs.

Patients and methods
====================

### Patients

In total, 45 patients with SPNs were identified using conventional X-ray and CT scanning at the Affiliated Hospital of Jining Medical University (Shandong, China) between January, 2013 and January, 2016. In general, the patients were asymptomatic despite some blood-tinged sputum. All 45 cases were verified by pathological or clinical means. The inclusion criteria for the study included: i) Nodule diameter, ≤3 cm; ii) nodules had certain sharp edges and could be measured for diameter; iii) presence of other lesions were present within the lung, but nodular morphology was readily distinguishable; and iv) lesion had cavities or calcification. The exclusion criteria for the present study included: i) History of lung injury, surgery or radiation exposure; and ii) definitive history of lung cancer or other cancer types. The study comprised 29 men and 16 women, aged 34--78 years, with an average age of 56.9±12.6 years. Twenty-three cases had SPNs in the left lung and 22 in the right. The nodule diameter was 0.5--2.8 cm, and the average diameter was 1.6±0.7 cm.

The present study was approved by the Ethics Committee of the Affiliated Hospital of Jining Medical University. Informed consent was obtained from patients and their families.

### Imaging analysis

A 64-layer spiral CT scanner from GE Medical Systems (Waukesha, WI, USA) was used. Scans were acquired under the following parameters: Voltage 120 kV, current 225 mA, rotational speed 0.4 sec/turn, dot spacing 0.531, FOV 20--24 cm, matrix 512×512, and 5-mm layer thickness. To capture the images, patients were trained to inspire and hold their breath in a supine position, and the area scanned was from the pleural entrance to the costophrenic angle, including all the pulmonary fields. After the lesions were found, local 0.625-mm thin-layer scanning was conducted and high-resolution algorithms were used to reconstruct the image in combination with dynamic enhanced scanning. Advanced lung analysis software (3D-ALA; GE Healthcare, Piscataway, NJ, USA) on a LightSpeed VCT GE AW 4.4 working station was used to conduct post-analysis processing including 3D-volume reproduction (VR), multiplanar reconstruction, MiniP recombination, and other parameters, as well as store images.

### Observation indexes

The following observation indexes were defined as follows: i) Lobular sign: For diagnosis, the arc of the lobular portion was taken as the standard. Lobules with a ratio of chord distance to a length ≥0.4 were classified as a deep lobule, those with a ratio between 0.2 and 0.4, and those with ratio of ≤0.2 were classified as shallow lobules. Lobules with chord distance of ≤4 mm were defined as thin lobules. Thin lobular sign on VR image was manifested as multiple ball-shaped protuberances on the nodule surface, the protuberance diameter was n≤5.0 mm, and the number of protuberances was \>5, presenting as a thin nodule-shape. ii) Spicule sign: spicules measuring \<5 mm were defined as thin and short spicules, and those measuring \>5 mm were classified as thick and long spicules. iii) Vacuole sign: Non-consolidated alveolar air shadows were visible within lobules. iv) Calcification: CT value was ≤200 HU. v) Pleural indentation sign: The regular linear shadow extracted pleura from the nodule, and the pleural indentation formed a typical horn mouth shape. vi) Spiculate protuberance: Nodule edges protruded sharply with the appearance of a small triangle. vii) Fat: Negative values corresponding to fat density were detected within nodules.

### Statistical analysis

Data were analyzed using SPSS 19.0 statistical software. Quantitative data were presented as mean ± standard deviation. The t-test was used for comparison among groups. Qualitative data were expressed as case number or percentage (%) and calibration. The χ^2^ test was used for comparison among groups. The diagnostic value of CT enhancement was calculated according to the formulae: Sensitivity, true positivity/(true positivity + false negativity) case number × 100%; specificity, true negativity/(true negativity + false positivity) case number × 100%; predicated positive value, true positivity/(true positivity + false positivity) case number × 100%; and predicted negative value, true negativity/(true negativity + false negativity) case number × 100%. P\<0.05 was considered to indicate statistically significant difference.

Results
=======

### Comparison of nodule diameter and enhancement situation

According to the final diagnoses, there were 34 cases with SPNs (75.6%), 17 cases of squamous cell lung cancer, 14 cases of glandular cancer and 3 other cases (alveolar cell carcinoma). There were 11 benign cases (24.4%), 7 cases of cryptogenic organizing pneumonia, 3 cases of tuberculosis and 1 case of hamartoma. When the nodule diameter in the malignant group was compared with the benign group, the difference was not significant (P\>0.05). The nodules in the malignant group demonstrated a mostly inhomogeneous enhancement pattern while those in the benign group showed homogeneous enhancement patterns. The enhanced CT value in the malignant group was higher than that in the benign group, and the difference was statistically significant (P\<0.05) ([Table I](#tI-etm-0-0-3528){ref-type="table"}).

### Comparison of lobular and spicule signs

The proportion of nodules with lobular sign was significantly higher in the malignant group compared to the benign group (P\<0.05). The proportions of lobular sign and different lobular sign subtypes in the two groups were compared, and the differences were not statistically significant (P\>0.05) ([Table II](#tII-etm-0-0-3528){ref-type="table"}).

### Comparison of other indexes

The proportion of nodules with vessel convergence and bronchus signs in the malignant group were significantly higher than that in the benign group, while calcification was significantly lower than that in the benign group (P\<0.05). Following a comparison of vacuole sign, pleural indentation sign, spiculate protuberance and presence of fat between the two groups, no significant differences were observed between the two groups (P\>0.05) ([Table III](#tIII-etm-0-0-3528){ref-type="table"}).

### Diagnostic value of CT enhancement

Following calculation according to the abovementioned formulae, the sensitivity was 85.6%, specificity was 79.6%, predicted positive value was 92.3%, and predicted negative value was 85.2%.

Discussion
==========

Previous evidence showed that the size of lesions shown by CT were basically identical with those after surgery, and correlation coefficients on the x-, y- and z-axes were 0.710, 0.944 and 0.875, respectively ([@b7-etm-0-0-3528]). SPN diameter may influence the pathological nature of the nodule and corresponding clinical manifestations. As nodule diameter increased, the probability that the nodule was malignant increased significantly. SPN diameter was previously shown to be an independent risk factor for the determination of benignity or malignancy ([@b8-etm-0-0-3528]). If nodule diameter exceeded 1 cm, this was considered an important value for judgement on the nature of the SPN. However, a small nodule did not exclude the possibility of lung cancer. Fifteen percent of malignant nodules had a diameter of \<1 cm, and 42% of nodules had a diameter of \<2 cm ([@b9-etm-0-0-3528]). At present, CT scanning for SPN growth measures primarily the maximum transverse diameter, maximum area, and volume of nodules. Measurements of the maximum transverse diameter and maximum area are simple and practical to perform, and nodule volume reflected tumor growth more accurately. The 64-row CT LungCare software (Siemens, Erlangen, Germany) is capable of early detection of SPN growth.

A previous study using dynamic enhanced CT for the evaluation of SPNs showed that, the occurrence rate of nodules with lobular sign was 70--100%, and 80--90% of lobular nodules were malignant lesions. Therefore, the lobular sign was the most common and fundamental sign for the diagnosis of peripheral lung cancer ([@b10-etm-0-0-3528],[@b11-etm-0-0-3528]). The pathogenic mechanism determining the appearance of lobular sign in lung cancer ([@b12-etm-0-0-3528]) includes: Different degrees of tumor cell differentiation, varying growth speeds at different parts of the tumor edge; the reaction of surrounding tissue, secondary to tumor growth; indentations or incisures generated from tumor growth restriction caused by blood vessels and connective tissues which grew from the inside to the outside of the tumor. The local anatomical structure of lung tissue is composed of connective tissues in the bronchus and blood vessels. In the event of their obstruction, growth of secondary pulmonary lobules is restricted. Due to the volume of small cell lung cancers, they have more shallow lobular signs. HRCT is therefore a more efficient method for observation of shallow lobules of small nodules ([@b13-etm-0-0-3528]). The observation of deep lobules is also a significant diagnostic sign and its mechanism of formation was shown to be multinuclear tumor cells merging or inhomogeneous growth of different parts of the tumor ([@b14-etm-0-0-3528]). The outermost edge of a lobule may be the apex of tumor growth, where the tumor-infiltrating neighboring lung tissue was evident, and limited four-indentation at lump edge was formed by obstruction of pulmonary supporting structures such as blood vessel and proliferated fibrous tissues ([@b15-etm-0-0-3528]).

Spicule sign was shown to be the main differential diagnostic marker of pulmonary nodules, and the detection rate of lung cancer was approximately 90.0% ([@b16-etm-0-0-3528]). The degree of fibrous tissue proliferation within a nodule and surrounding it correlated with the amount of spicules at its edge. Tumor cells gained the capacity for infiltrative growth along alveolar walls, lymphatic vessels, and blood vessels and this was the main factor contributing to the formation of spicule signs ([@b17-etm-0-0-3528]). The causes of pleural indentation include ([@b18-etm-0-0-3528]), fibrotic contraction within the tumor body, accompanied or unaccompanied by pleural thickening and adhesion. Tumors can directly invade the pleural edge, and the affected direction of the pleural indentation sign was identical with the direction of bronchial blood vessel bundles of the pulmonary lobe where the lump was located. Whether pleural four-indentation sign was formed was related to lump size and its distance from the pleural plane. Vessel convergence sign represented one or multiple blood vessels infiltrating the tumor body or traversing it, the pulmonary vessel being removed and translocated to the tumor, or blood vessels reaching the tumor edge. Its occurrence rate in peripheral lung cancer was approximately 65.0% ([@b19-etm-0-0-3528]). Expanded bronchioles can form an air bronchogram, and the effects of tumors on bronchi include the truncation of the bronchus by a tumor edge, a bronchus being contained by the tumor, and the lumen of the bronchus being pressed and translocated with thickening of the smooth mucous membrane layer of the bronchial wall ([@b20-etm-0-0-3528]). Other changes include the transmigration stenosis of the lumen and irregular stenosis. Malignant SPNs can cause changes to bronchi including sudden truncation, normality, translation and cone stenosis ([@b21-etm-0-0-3528]). Calcification is a powerful index in CT for the identification of benign SPNs. Nodule calcification manifests as different forms including center, stratiform, popcorn, needle tip and permeating types. Minor calcifications were found in a small proportion of lung cancers, and the calcified area of the malignant nodules generally did not exceed 10% of the lesion ([@b22-etm-0-0-3528]). Fat was not found in any lung cancer or pulmonary sarcoma, only in benign lesions (hamartoma and lipoid pneumonia) ([@b23-etm-0-0-3528]).

In the present study, when the nodule diameter in the malignant group was compared with that of the benign group, the difference was not statistically significant (P\>0.05). Nodules in the malignant group were characterized by inhomogeneous enhancement while nodules in the benign group were characterized by homogeneous enhancement. The enhanced CT value in the malignant group was higher than that in the benign group, and the difference was statistically significant (P\<0.05). When the proportions of lobular sign and its subtypes in the two groups were compared, the differences were not significant (P\>0.05). The proportions of calcification, vessel convergence sign and bronchus sign in the malignant group were significantly higher than those in the benign group (P\<0.05). By contrast, comparisons of vacuole sign, pleural indentation sign, spiculate protuberance and fat occurrence between the two groups were not significantly different (P\>0.05). The sensitivity of CT enhancement was 85.6%, specificity was 79.6%, predicted positive value was 92.3% and predicted negative value was 85.2%. In conclusion, CT enhancement mediating the diagnosis of SPNs was mainly manifested at the enhancement degree, lobular sign, calcification, vessel convergence sign and bronchus sign with high diagnostic accuracy.

###### 

Comparison of nodule diameter and enhancement.

  Groups          Case no.   Nodule diameter (cm)   Homogeneous enhancement           Inhomogeneous enhancement   CT enhancement value (HU)
  --------------- ---------- ---------------------- ------------------------- ------- --------------------------- ---------------------------
  Malignant       34         1.5±0.8                5 (14.7)                          29 (85.3)                   142.6±36.9
  Benign          11         1.6±0.5                7 (63.6)                          4 (36.4)                    105.7±28.5
  t (χ^2^)-test              0.657                                            7.827                                 5.629
  P-value                    0.849                                            0.005                                 0.033

CT, computed tomography.

###### 

Comparison of lobular sign and spicule sign \[case (%)\].

  Groups      Case no.   Lobular sign   Deep lobule   Medium lobule   Shallow lobule   Thin lobule   Spicule sign   Thin and short spicule           Thick and long spicule
  ----------- ---------- -------------- ------------- --------------- ---------------- ------------- -------------- ------------------------ ------- ------------------------
  Malignant   34         27 (79.4)      7 (20.6)      14 (41.2        6 (17.6)         8 (23.5)      25 (73.5)      19 (55.9)                        6 (17.6)
  Benign      11         4 (36.4)       1 (9.1)       2 (18.2)        1 (9.1)          1 (9.1)       6 (54.5)       3 (27.3)                         3 (27.3)
  χ^2^                   5.318                                                                       0.652                                   0.576   
  P-value                0.021                                                                       0.419                                   0.448   

###### 

Comparison of other indexes \[case (%)\].

  Groups      Case no.   Vacuole sign   Calcification   Pleural indentation sign   Spiculate protuberance   Fat        Vessel convergence sign   Bronchus sign
  ----------- ---------- -------------- --------------- -------------------------- ------------------------ ---------- ------------------------- ---------------
  Malignant   34         15 (44.1)      10 (29.4)       17 (50.0)                  10 (29.4)                7 (20.6)   26 (76.5)                 28 (82.4)
  Benign      11         2 (18.2)       8 (72.7)        4 (36.4)                   2 (18.2)                 3 (27.3)   4 (36.4)                  3 (27.3)
  χ^2^                   1.403          4.818           0.621                      0.116                    0.002      4.347                     4.053
  P-value                0.236          0.028           0.431                      0.734                    0.963      0.037                     0.044

[^1]: Contributed equally
